Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRbg Holdings Regulatory News (RBGP)

Share Price Information for Rbg Holdings (RBGP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12.25
Bid: 12.00
Ask: 12.50
Change: 0.50 (4.26%)
Spread: 0.50 (4.167%)
Open: 11.75
High: 12.25
Low: 11.75
Prev. Close: 11.75
RBGP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

18 Dec 2023 07:00

RNS Number : 1080X
RBG Holdings PLC
18 December 2023
 

18 December 2023

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014 as retained as part of UK law by virtue of the European Union (Withdrawal) Act 2018 (as amended). Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

RBG Holdings plc

("RBG", the "Group", or the "Company")

 

Trading Update

 

RBG Holdings plc (AIM: RBGP), the legal and professional services group, today publishes a trading update for the twelve months ending 31 December 2023 ("FY 2023").

 

2023 has been a pivotal year for the Group. The new leadership team has taken action to reduce the Group's risk profile and refocus on its core business activities where the Board believes it can best maximise profits. These key actions include:

 

Reduce Risk

· the disposal of LionFish

· scaling back from unfunded Alternative Billing Arrangements ("ABAs") and no longer carrying investments in ABAs as assets on the balance sheet

 

Increase Stability

· appointment of a new Chief Financial Officer, Kevin McNair

· renewing banking facilities totalling £24.5m at interest rates deemed favourable by the Board

 

Focus on Growth

· the recruitment of seven new partners who have already started to gain traction in their specific markets and are generating new revenue streams

 

Prudent Financial Management

· suspension of the dividend policy

· a full root and branch review of all aspects of the accounting treatments of work in progress and debtors

· an increase in bad debt provisions

 

Operational Management

· implementation of new ERP management information system

· instruction of two agents on the Group's leasehold properties to consolidate its property portfolio

 

Trading

 

Legal Services

In its results for the six months ended 30 June 2023, the Company announced that Legal Services performed broadly in line with the Board's expectations during H1 2023, despite the challenging economic conditions.

 

The second half of the financial year has historically been the stronger of the two halves, however activity levels during H2 2023 have been at similar levels to H1 2023 and there has not been the increase in revenue and profitability seen in previous years and that the Board had anticipated. In particular, Memery Crystal, has been impacted by the lack of activity in both Commercial Real Estate and Equity Capital Markets with transactions that were forecast in Q4 2023 either being delayed into 2024 or cancelled altogether.

 

Corporate Finance Advisory

The Group's specialist sell-side corporate finance advisory business, Convex Capital, continues to have a strong pipeline of 18 deals. A number are in advanced stages of negotiations and had been forecast to complete in Q4, but transactions are taking significantly longer to complete in 2023 as a consequence of the current economic environment and weakness in the M&A market. Convex Capital completed three transactions this year delivering total fee income of £2.19m versus a previous Board expectation of £4.5m. Until recently, the Board had confidence over its expectation but it has now become clear that no more transactions will complete this side of the financial year end. The pipeline is positioned to deliver the delayed transactions in 2024. 

 

Financial Performance

 

LionFish & ABA costs

· Lionfish: the disposal resulted in a reported loss on disposal of £0.7m; an adverse cost ruling regarding a case prior to the disposal has subsequently incurred a settlement of £0.4m net of insurance.

· The change in accounting policy set out in the RNS of 27 July 2023 has resulted in disbursements of £0.72m being expensed during the period; these were incurred in respect of the final remaining large ABA - any successful outcome will be returned to the Group as revenue.

 

Debtors & Work in Progress:

· As part of the recent re-financing exercise undertaken during the second half of 2023 and concluded in December, management undertook a comprehensive review of the historic debtor book and the historic work in progress being carried on the balance sheet. Some was very historic in nature and the decision has been taken to write off £1.8m of debtors and work in progress. As this will be a change in accounting policies, it will require a restatement of the 2022 accounts.

 

Legal & Professional fees: 

· Costs relating to employment cases under the previous leadership team have been incurred (principally in the second half) totalling £1.9m.

· In addition, a further c. £0.2m was incurred during H2 in the run-down of another ABA.

 

As a result of the various factors set out above, the Board now expects that revenue for FY 2023 will be slightly lower than market expectations at approximately £42m and adjusted EBITDA is expected to be approximately £4m1. The table below sets out comparable figures for FY 2022 and FY 2023. These figures do not include the impact of LionFish, a discontinued business, in either period.

 

Revenue (£m)

H2 2023

H2 2022

 

FY 2023

FY 2022

Legal services

19.4

23.8

39.7

44.5

Convex

1.5

1.1

2.2

5.3

Total

20.9

24.9

41.9

49.8

Adjusted EBITDA (£m)

1.6

8.8

c. 4.0

15.8

The Company recently announced that it had renewed and extended its existing borrowing facilities with its current lender, HSBC, under which the debt headroom was raised to £24.5m. The Company had a pre-IFRS 16 net debt position of £22.1m as at 15 December 2023. Under the Board's base case scenario which includes improved working capital management, the Company has sufficient cash headroom over the next 12 month period.

Commenting on the Trading Update and Outlook for FY 2023, Marianne Ismail, Non-Executive Chair of RBG Holdings plc, said:

"The Board recognises that FY 2023 has been a year of significant transition and a disappointing one for shareholders. Nonetheless, the Board is confident that the business is moving into FY 2024 on a significantly stronger footing than at the start of this year. 

"I would like to thank the new management team for the bold decisions taken in tackling historical issues that have drained the business of management time, profit and working capital during 2023. 

"The Group now has noticeably improved operating processes that will begin feeding through in terms of improved margins in 2024. Our new agreement with HSBC gives the team operational headroom to deleverage the business while it brings performance back up to acceptable levels.

"There are early signs of recovery in some of the key areas of legal services that were badly impacted in 2023 but we will be presenting a more conservative budget for 2024, with revenue and profit expected to be slightly higher than 2023, that is designed to demonstrate both clarity and profitability to investors and other key stakeholders. 

"Continuing to improve the Group´s operational efficiency, expand margins and generate cash are the key priorities for the Board and management team going forward. We will continue to review our costs in light of our revenues and the market conditions."

The person responsible for the release of this announcement is Kevin McNair, Chief Financial Officer.

1Adjusted for £11.4m of litigation write offs, £1.4m of legal and professional fees, £2.8m of Lionfish costs and £0.9m of other non-underlying costs

Enquiries:

RBG Holdings plc

Jon Divers, Chief Executive Officer

Kevin McNair, Chief Financial Officer 

 Via SEC Newgate

 

 

Singer Capital Markets (Nomad and Broker)

Rick Thompson / Alex Bond / James Fischer (Corporate Finance)

Tom Salvesen (Corporate Broking)

 

 

Tel: +44 (0)20 7496 3000

SEC Newgate (for media/analyst enquiries)

Tali Robinson / Robin Tozer

Tel: +44 (0)7970 664807

rbg@secnewgate.co.uk

 

About RBG Holdings plc

· Further information about RBG Holdings plc is available at:  www.rbgholdings.co.uk

· Further information about Rosenblatt (founded in 1989) is available at:  www.rosenblatt.co.uk

· Further information about Memery Crystal (founded in 1979) is available at:  www.memerycrystal.com

· Further information about Convex Capital (founded in 2010) is available at:  www.convexcap.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTTRBTTMTIBTMJ
Date   Source Headline
8th Apr 20243:37 pmRNSHolding(s) in Company
8th Apr 202412:43 pmRNSHolding(s) in Company
4th Apr 20247:00 amRNSNotice of Results & Investor Presentation
28th Mar 20241:00 pmRNSDisposal of Convex Capital & Directorate Change
14th Mar 20242:01 pmRNSDirector/PDMR Dealings
12th Mar 202411:50 amRNSResult of General Meeting
12th Mar 20247:00 amRNSAIM Rule 17 Schedule Two (g) Update
11th Mar 20247:00 amRNSResult of Retail Offer
28th Feb 202411:03 amRNSHolding(s) in Company
23rd Feb 20247:00 amRNSRetail Offer
22nd Feb 20243:33 pmRNSResult of Placing and Subscription
22nd Feb 20247:00 amRNSProposed Fundraising and Notice of GM
10th Jan 20241:56 pmRNSHolding(s) in Company
19th Dec 20235:24 pmRNSHolding(s) in Company
18th Dec 20237:00 amRNSTrading Update
11th Dec 20237:00 amRNSRefinancing and Convex Capital Update
29th Nov 20237:00 amRNSDirectorate Change
31st Oct 20237:00 amRNSConvex Capital Update
30th Oct 20237:00 amRNSStatement Confirming Settlement
5th Oct 20235:40 pmRNSHolding(s) in Company
3rd Oct 20235:30 pmRNSHolding(s) in Company
2nd Oct 20236:21 pmRNSPDMR / PCA Dealing
28th Sep 20237:00 amRNSUnaudited Interim Results
11th Sep 20237:00 amRNSNotice of Results
31st Jul 202312:42 pmRNSDirector/PDMR Shareholding
31st Jul 20237:00 amRNSIan Rosenblatt appointed as an Executive Director
27th Jul 20237:00 amRNSPre-close Trading and Business Update
26th Jul 20234:13 pmRNSHolding(s) in Company
12th Jul 20237:00 amRNSSale of LionFish Litigation Finance Limited
27th Jun 20237:00 amRNSDirectorate Change
22nd Jun 202311:11 amRNSResult of AGM & Directorate Change
23rd May 20239:07 amRNSNotice of AGM and Dividend
17th May 20233:28 pmRNSHolding(s) in Company
26th Apr 20237:00 amRNSResults for the year ended 31 Dec 2022
18th Apr 20237:00 amRNSNotice of Investor Presentation
3rd Mar 202312:44 pmRNSCorrection: Board Changes and Notice of Results
3rd Mar 202312:18 pmRNSBoard Changes and Notice of Results
31st Jan 20237:00 amRNSBoard Changes & Pre-Close Trading Update
3rd Jan 20237:00 amRNSDirectorate Changes
12th Dec 20227:00 amRNSDirector/PDMR Shareholding
7th Dec 20227:00 amRNSDirector/PDMR Shareholding
6th Dec 20227:00 amRNSDirector/PDMR Shareholding
5th Dec 20222:05 pmRNSSecond Price Monitoring Extn
5th Dec 20222:00 pmRNSPrice Monitoring Extension
5th Dec 202211:05 amRNSSecond Price Monitoring Extn
5th Dec 202211:00 amRNSPrice Monitoring Extension
5th Dec 20229:05 amRNSSecond Price Monitoring Extn
5th Dec 20229:00 amRNSPrice Monitoring Extension
5th Dec 20227:00 amRNSTrading & Dividend Update
13th Sep 20227:00 amRNSUnaudited Interim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.